Implicity vs Navina

A cardiac device clinic monitoring pacemakers, ICDs, CRT devices and insertable loop recorders from Abbott, Biotronik, Boston Scientific, Medtronic and MicroPort is Implicity's buyer. The cloud platform scores heart failure risk from device data (SignalHF) and filters atrial fibrillation alerts. OpenFDA lists SignalHF's clearance, K230842, on October 25, 2023, while the vendor's press release gives May 17, 2024. The vendor says its ILR ECG Analyzer cuts false positives 79% on Medtronic recordings at 99% sensitivity. A 2023 Europace evaluation of its insertable-monitor algorithm, 879 abnormal episodes in 546 patients with Implicity authors, reported 98.6% sensitivity and 76.0% specificity. A funding-news page says the platform "can integrate with electronic health records," and the vendor's home page names no EHR.

Navina sells to primary care groups, such as the Privia Health and Agilon Health logos on its homepage. The homepage names athenahealth, Epic and Veradigm, and the vendor says 20,000+ clinicians and care team members use it. A device clinic watching implant alerts and a primary care group working an attributed population are not weighing these two against each other.